Osman Can

Osman Can

Auto-generated profile, based on publicly available information

Osman Can

Department of Urology, Basaksehir Çam Sakura City Hospital, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2021 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
OCOsman Can
Osman Can
MEMustafa Erkoç
Mustafa Erkoç
MOMurat Ozer
Murat Ozer
MKMusab Umeyir Karakanli
Musab Umeyir Karakanli
AOAlper Otunctemur
Alper Otunctemur
Aims: The COVID‐19 pandemic is the most important public health problem in 2020. Millions of people have been infected or died because of the outbreak. We know the common symptoms of the disease such as fever and cough. However, all symptoms and features of COVID‐19 are still were not known. We aimed to evaluate the change in lower urinary tract symptoms (LUTS) after COVID‐19 in men.Methods: We prospectively assessed 94 patients with COVID‐19 during hospitalisation. The patients were divided into two groups according to age, that being over and under age 50. IPSS scores of all patients were enrolled. Additionally, we compared the scores with pre‐COVID‐19 values.Results: LUTS scores were found to be increased in elderly patients. Additionally, the severity of the disease did not correlate with LUTS scores.Conclusion: LUTS may be one of the symptoms of COVID‐19 in some patients. Elderly patients with increased LUTS should be evaluated for COVID‐19 when the reason unclear.

5 August 2019 in Urolithiasis
Verified
Journal Article
Closed access
PDF file
SÖSait Özbir
Sait Özbir
OCOsman Can
Osman Can
HAHasan Anıl Atalay
Hasan Anıl Atalay
HCHalil Lütfi Canat
Halil Lütfi Canat
SÇSüleyman Sami Çakır
Süleyman Sami Çakır
AÖAlper Ötünçtemur
Alper Ötünçtemur

1 January 2018 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
IAİlter Alkan
İlter Alkan
MYMERAL Yuksel
MERAL Yuksel
HCHalil Lütfi Canat
Halil Lütfi Canat
HAHasan Anıl Atalay
Hasan Anıl Atalay
OCOsman Can
Osman Can
MBMehmet Murad Başar
Mehmet Murad Başar
Alkan İ, et al. World J Mens Health. 2018 Jan;36:e28. https://doi.org/10.5534/wjmh.180028

28 March 2024 in Journal of Laparoendoscopic & Advanced Surgical Techniques
Verified
Journal Article
Closed access
MEMustafa Erkoc
Mustafa Erkoc
MBMuammer Bozkurt
Muammer Bozkurt
MSMehmet Ali Sezgin
Mehmet Ali Sezgin
LOLevent Ozcan
Levent Ozcan
OCOsman Can
Osman Can
AOAlper Otunctemur
Alper Otunctemur
Backgrounds: In the renal intrarenal stone surgery (RIRS) procedure, ureteral access sheath (UAS) is still used in the majority of surgeries to both protect the flexible ureteroscope (FURS) and reduce intrarenal pressure. ClearPETRA is a new UAS that has an integrated aspiration port. We aimed to evaluate the clinical outcomes and effectiveness of Aspiration-Assisted UAS (ClearPETRA) in the RIRS procedure. Methods: One thousand six hundred twenty patients who underwent RIRS between January 2021 and January 2024 were evaluated retrospectively and 512 patients were included in the study. According to stone size, patients with stones less than 2 cm and those with stones between 2 and 3 cm were analyzed separately. Patient's demographic data, stone size, body mass index, Extracoporeal Shockwave Lithotripsy (ESWL) history, stone side, stone density (Hounsfield Unit), operation time, stone-free rate (SFR), and the number of patients with sepsis were recorded. SFR was evaluated with kidney urinary bladder 3 months after surgery for opaque calculi. Nonopaque calculi patients were evaluated with noncontrast computed tomography 3 months after surgery. In the postoperative evaluation, patients with stones less than 4 mm were evaluated as SFR. P value of <0.01 was considered statistically significant. Results: Patient's demographic data, stone characteristics, and history of ESWL were similar in the ClearPETRA and UAS groups (P > .05). A total of 328 patients who underwent RIRS for stones less than 2 cm were included (80 ClearPETRA, 248 UAS). Length of hospital stay, operation time, SFR, secondary intervention, or postoperative sepsis (P ≥ .01) were similar in both groups. The incidence of postoperative fever was statistically significantly lower in the ClearPETRA group (P = .006). A total of 184 patients who underwent RIRS for stones between 2 and 3 cm were included (42 ClearPETRA, 142 UAS). In the ClearPETRA group, operation time was statistically significantly shorter (P = .002), SFR was statistically significantly higher (P = .003), and the number of fever and sepsis were statistically significantly less (P = .003 and 0.002, respectively). Conclusion: We found that ClearPETRA reduces the likelihood of postoperative fever after RIRS surgeries. Moreover, we can say that the use of ClearPETRA in RIRS, especially for stones larger than 2 cm, reduces the operation time, increases the SFR, and also reduces sepsis rates.

1 January 2019 in Urology Research and Practice
Verified
Journal Article
Closed access
HAHasan Anıl Atalay
Hasan Anıl Atalay
VUVolkan Ulker
Volkan Ulker
LCLütfi Canat
Lütfi Canat
MÖMurat Özer
Murat Özer
OCOsman Can
Osman Can
KPKristina L. Penniston
Kristina L. Penniston
Objective: We validated the Turkish version of the Wisconsin Stone-Quality of Life (WISQoL) questionnaire for male and female patients with kidney stones. Material and methods: The Turkish version of the WISQoL questionnaire was developed following a well-established multistep process. A total of 84 patients with kidney stones completed the Turkish WISQoL questionnaire, including the other validated questionnaires as The Short Form Health Survey (SF-36 v2) and Beck's Depression Inventory. Patients completed questionnaires before percutaneous nephrolithotomy (PNL) surgery as well as 2–4 weeks after surgery. Reliability was evaluated by internal consistency (tested by Cronbach’s alfa) and test-retest reliability between week 2 and 4 (tested by Spearman correlation). Domain structures were examined by interdomain correlations using Spearman correlation coefficient. Convergent validity was assessed by correlating the scores of general health domain to the SF-36 v2, and the scores of emotional impact domain to the Beck's Depression Inventory questionnaire. Sensitivity to change was assessed by comparing scores before and after PNL surgery with the Wilcoxon signed rank test. Discriminant validity was evaluated by comparing the results of patients 2 and 4 weeks after surgery with Wilcoxon-rank sum tests. Results: The Turkish version of the WISQoL demonstrates good internal consistency (Cronbach’s α=0.72-0.78) and test–retest reliability (p>0.05). Inter-domain associations within the WISQOL showed a substantial correlation between various WISQoL domains, indicating a high conceptual relationship between the domains. Also, the Turkish version of the WISQoL showed convergent validity with the corresponding validated questionnaires (Spearman’s rho correlation coefficient=0.44-0.78). All domains of the WISQoL showed significant sensitivity to change (p≤0.001). Conclusion: The Turkish version of the WISQoL is a generally reliable instrument that can be self-administered by Turkish patients with kidney stones in clinical and research settings. Further clinical studies in Turkish settings would be useful to provide powerful data on sensitivity to change. Cite this article as: Atalay HA, Ülker V, Canat L, Özer M, Can O, Penniston KL. Validation of the Turkish version of the Wisconsin stone-quality of life questionnaire. Turk J Urol 2019; 45(2): 118-23.

5 January 2024 in Surgical Oncology
Verified
Journal Article
Closed access
OCOsman Can
Osman Can
EDEyyüp Danış
Eyyüp Danış
EKEren Görkem Kutlutürk
Eren Görkem Kutlutürk
EPEmre Can Polat
Emre Can Polat
AÖAlper Ötünçtemur
Alper Ötünçtemur